Shanghai, China

Shanzhong Jian

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Shanzhong Jian: Innovator in Kinase Inhibitors

Introduction

Shanzhong Jian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 5 patents to his name, Jian's work focuses on compounds that have the potential to treat various diseases, including cancers.

Latest Patents

Jian's latest patents include innovative compounds that serve as kinase inhibitors. One of his notable patents describes heterocyclic compounds that are potentially useful in the treatment of diseases such as cancers. The patent outlines a compound of Formula (I) and/or its stereoisomers, tautomers, stable isotopes, or pharmaceutically acceptable salts. Additionally, he has developed pharmaceutical compositions that incorporate these compounds along with acceptable carriers. Another patent focuses on compounds that inhibit tryptophan 2, 3-dioxygenase 2 (TDO2) and indoleamine 2, 3-dioxygenase 1 (IDO1), which are also aimed at treating cancers.

Career Highlights

Throughout his career, Shanzhong Jian has worked with various companies, including Js Innopharm (Shanghai) Ltd. and Changzhou Jiekai Pharmatech Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Jian has collaborated with notable colleagues in his field, including Jintao Zhang and Wen Kang Xu. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Shanzhong Jian is a distinguished inventor whose work in kinase inhibitors has the potential to make a significant impact in the treatment of cancer. His innovative compounds and collaborations highlight his commitment to advancing medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…